Celltrion chairman\

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...

The Seoul Metropolitan Police Agency has launched an investigation into social media accounts pretending to be Hyundai Motor Group advisor Sung Kim,...

South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...

South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...

La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...

South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...

HD Hyundai Co., the holding company of South Korea’s No. 1 shipbuilding conglomerate, on Thursday shuffled its top management. In it, Vice Cha...

South Korean steel giant POSCO Holdings Inc. is seeking to sell its entire stake in a Chinese stainless steel joint venture as it faces growing comp...

MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...

South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...

South Korea’s top automaker Hyundai Motor Co. on Thursday unveiled a new hydrogen fuel cell electric vehicle (FCEV) concept, previewing its ne...

South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...

South Korea’s POSCO Group joined hands with India’s JSW Group to set up an integrated steel plant in the South Asian country with an est...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...

South Korea’s National Pension Service (NPS) will raise exposure to residential housing and data centers to take advantage of lower interest r...

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...

South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...

Lotte Group has selected Pepero — a thin chocolate-covered stick cookie — as the first brand that it will foster into one of the world&r...

Akio Toyoda, chairman of Japan’s top automaker Toyota Motor Corp., will fly to Seoul in late October to meet with Hyundai Motor Group Chairman...

South Korea's HD Hyundai Co. established the HD Hyundai Hope Foundation (tentative name) to support the families of victims of major industrial acci...

Challenges are ahead but the artificial intelligence industry will eventually boom, opening new markets, said South Korea’s second-largest bus...

South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...

South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...